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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Divergent roles of 
Smad3 and PI3-kinase 
in murine adriamycin 
nephropathy indicate 
distinct mechanisms 
of proteinuria and 
fibrogenesis
Proteinuria is a strong predictor of 
chronic kidney disease (CKD) pro-
gression, and renal fibrosis occurs in 
nearly all forms of progressive CKD. 
Many studies have implicated a central 
role for transforming growth factor-b 
(TGF-b) in promoting glomerular dis-
ease and renal fibrosis. In this issue, 
Finer et al. report studies using a novel 
murine adriamycin nephropathy model 
of focal glomerulosclerosis. They found 
that TGF-b inhibition ameliorated renal 
fibrosis in adriamycin-treated mice 
without reducing proteinuria. Further 
studies revealed that early podocyte 
injury and subsequent proteinuria 
were characterized by activation of the 
p110g isoform of PI3-kinase and that 
administration of a specific inhibitor 
of p110g reduced adriamycin-induced 
proteinuria in vivo but had no effect on 
TFG-b-induced fibrogenesis in vitro. 
These studies demonstrate that protein-
uria and fibrosis in glomerular disease 
may occur via distinct mechanisms. 
See page 525.
The early decline 
in renal function 
in patients with 
type 1 diabetes and 
proteinuria predicts 
the risk of end-stage 
renal disease
Though previous studies have demon-
strated that patients with type 1 diabetes 
mellitus and proteinuria are at increased 
risk of end-stage renal disease (ESRD), 
clinicians cannot accurately predict their 
rate of decline in glomerular filtration 
rate. Skupien et al. followed a cohort of 
161 patients with type 1 diabetes melli-
tus, proteinuria, and estimated glomeru-
lar filtration rate (eGFR) ≥ 60 ml/min 
at baseline for 5–18 years. They found 
the eGFR decline slow and the ESRD 
risk minimal in more than one-third 
of patients. However, in the remaining 
patients, the rate of decline and ESRD 
risk were more variable. Importantly, 
the investigators demonstrated that 
the rate of decline in eGFR during the 
first 5 years of follow up in patients with 
type 1 diabetes mellitus and proteinuria 
strongly predicted subsequent risk of 
ESRD. See page 589.
Vitamin K intake 
and status are low in 
hemodialysis patients
Vitamin K-dependent carboxylation 
is required for the normal function of 
proteins with g-carboxyglutamate (Gla) 
residues, including matrix Gla protein 
(MGP), the strongest known inhibitor 
of vascular calcification. Cranenburg 
and colleagues studied dietary vita-
min K intake in a cohort of hemodi-
alysis patients and correlated dietary 
vitamin K with plasma levels of non-
carboxylated Gla-containing proteins. 
Hemodialysis patients had markedly 
lower vitamin K intake compared with 
healthy controls and also had much 
higher levels of non-carboxylated Gla 
proteins, including MGP. This valuable 
study suggests that low dietary vitamin 
K may be an important contributor to 
vascular calcification in patients receiv-
ing hemodialysis. See page 605.
